Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world observational study of ixazomib in multiple myeloma patients with functional constipation
ChiCTR2100045236Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ixazomib in multiple myeloma (MM), sponsored by West China Hospital of Sichuan University. Primary endpoint: Objective response rate. Started May 2021; status: recruiting.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR2100045236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045236.